Steven A Kaplan wetenschapper
Kaplan, Steven A.
Kaplan, S. A.
Kaplan, Steven A., 1957-
VIAF ID: 73208020 (Personal)
Permalink: http://viaf.org/viaf/73208020
Preferred Forms
- 100 1 _ ‡a Kaplan, S. A.
-
- 100 1 _ ‡a Kaplan, Steven A.
- 100 1 _ ‡a Kaplan, Steven A.
-
- 100 1 _ ‡a Kaplan, Steven A.
-
- 100 0 _ ‡a Steven A Kaplan ‡c wetenschapper
4xx's: Alternate Name Forms (1)
Works
Title | Sources |
---|---|
Male lower urinary tract symptoms and benign prostatic hyperplasia | |
Minimally invasive procedures in urology | |
Re: Intraprostatic botulinum toxin type a administration: evaluation of the effects on sexual function | |
Re: Intravesical Prostatic Protrusion as a Predictor of Early Urinary Continence Recovery after Laparoscopic Radical Prostatectomy | |
Re: Intravesical prostatic protrusion predicts clinical progression of benign prostatic enlargement in patients receiving medical treatment | |
Re: Involvement of estrogen receptors in prostatic diseases | |
Re: Laser Prostate Ablation and Enucleation: Analysis of a National Cohort | |
Re: Learning Curves and Perioperative Outcomes after Endoscopic Enucleation of the Prostate: A Comparison between GreenLight 532-nm and Holmium Lasers | |
Re: Long-Term Dutasteride Therapy in Men with Benign Prostatic Hyperplasia Alters Glucose and Lipid Profiles and Increases Severity of Erectile Dysfunction | |
Re: long-term survival of participants in the Prostate Cancer Prevention Trial. | |
Re: major depression drives severity of American Urological Association symptom index. | |
Re: Management of Male Lower Urinary Tract Symptoms in a Simulated, Over-the-Counter Setting: An Exploratory Study of Tamsulosin | |
Re: Medical Treatment of Nocturia in Men with Lower Urinary Tract Symptoms: Systematic Review by the European Association of Urology Guidelines Panel for Male Lower Urinary Tract Symptoms | |
Re: Meta-Analysis and Systematic Review of Intermediate-Term Follow-up of Prostatic Urethral Lift for Benign Prostatic Hyperplasia | |
Re: Metabolomics Analysis of Blood Identifies Potential Biomarkers and Possible Treatment Targets for Nocturia | |
Re: Metformin Inhibits the Proliferation of Benign Prostatic Epithelial Cells | |
Re: Morbidity and Mortality after Benign Prostatic Hyperplasia Surgery: Data from the American College of Surgeons National Surgical Quality Improvement Program. | |
Re: National, regional, and global trends in body-mass index since 1980: systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9.1 million participants | |
Re: national trends in surgical therapy for benign prostatic hyperplasia in the United States (2000-2008). | |
Re: Nocturia is More Bothersome than Daytime LUTS: Results from an Observational, Real-Life Practice Database Including 8659 European and American LUTS Patients | |
Re: Non-alcoholic fatty liver disease is associated with benign prostate hyperplasia in men and with overactive bladder in women | |
Re: Noninvasive methods to evaluate bladder obstruction in men. | |
Re: Oxidative Damage in Patients with Benign Prostatic Hyperplasia and Prostate Cancer Co-Exposed to Phthalates and to Trace Elements | |
Re: PDE5 inhibitors blunt inflammation in human BPH: a potential mechanism of action for PDE5 inhibitors in LUTS | |
Re: Pioglitazone attenuates prostatic enlargement in diet-induced insulin-resistant rats by altering lipid distribution and hyperinsulinaemia | |
Re: Polypharmacy, Chronic Kidney Disease, and Benign Prostatic Hyperplasia in Patients with Chronic Obstructive Pulmonary Disease Newly Treated with Long-Acting Anticholinergics | |
Re: Predictor of de novo urinary incontinence following holmium laser enucleation of the prostate | |
Re: predictors of successful first-line antimuscarinic monotherapy in men with enlarged prostate and predominant storage symptoms | |
Re: Predictors of Successful Trial without Catheter following Acute Urinary Retention in Benign Prostatic Enlargement: A Single Centre, Multivariate Analysis | |
Re: preperitoneal single-port transvesical enucleation of the prostate (STEP) for large-volume BPH: one-year follow-up of Qmax, IPSS, and QoL. | |
Re: prescriber monitoring for benign prostatic hyperplasia within a family medicine clinic: a comparison of medication classes | |
Re: Prevalence of Inflammation and Benign Prostatic Hyperplasia on Autopsy in Asian and Caucasian Men. | |
Re: Promising molecular targets and biomarkers for male BPH and LUTS | |
Re: Prospective comparative study of endoscopic management of bladder lithiasis: is prostate surgery a necessary adjunct? | |
Re: Prospective masked comparison of intraoperative floppy iris syndrome severity with tamsulosin versus alfuzosin. | |
Re: Prospective, multidimensional evaluation of sexual disorders in men after laser photovaporization of the prostate | |
Re: Prospective, Randomized, Multinational Study of Prostatic Urethral Lift versus Transurethral Resection of the Prostate: 12-Month Results from the BPH6 Study | |
Re: Prostate Artery Embolization in Patients with Prostate Volumes of 80 mL or More: A Single-Institution Retrospective Experience of 93 Patients | |
Re: PSA levels in men with spinal cord injury and under intermittent catheterization | |
Re: Quality of Life in Patients with Lower Urinary Tract Symptoms Associated with BPH: Change over Time in Real-Life Practice According to Treatment-The QUALIPROST Study. | |
Re: Randomised Clinical Trial of Prostate Artery Embolisation versus a Sham Procedure for Benign Prostatic Hyperplasia | |
Re: Randomized Controlled Trial on the Efficacy of Bladder Training before Removing the Indwelling Urinary Catheter in Patients with Acute Urinary Retention Associated with Benign Prostatic Hyperplasia | |
Re: Real-World Evidence of Prostatic Urethral Lift Confirms Pivotal Clinical Study Results: 2-Year Outcomes of a Retrospective Multicenter Study | |
Re: Recovery of Voiding Efficiency and Bladder Function in Male Patients with Non-Neurogenic Detrusor Underactivity after Transurethral Bladder Outlet Surgery | |
Re: Relationship among Diet Habit and Lower Urinary Tract Symptoms and Sexual Function in Outpatient-Based Males with LUTS/BPH: A Multiregional and Cross-Sectional Study in China | |
Re: Resveratrol Reduces the Levels of Circulating Androgen Precursors but has No Effect on Testosterone, Dihydrotestosterone, PSA Levels or Prostate Volume. A 4-Month Randomised Trial in Middle-Aged Men | |
Re: Risk Factors for Long-Term Outcome in Photoselective Vaporization of the Prostate | |
Re: robot-assisted simple prostatectomy | |
Treatment of Benign Prostatic Hyperplasia: Modern Alternative to Transurethral Resection of the Prostate |